These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Silveira MG; Lindor KD J Hepatol; 2008 May; 48(5):692-4. PubMed ID: 18336948 [No Abstract] [Full Text] [Related]
10. High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater? Chapman RW Hepatology; 2009 Sep; 50(3):671-3. PubMed ID: 19714717 [No Abstract] [Full Text] [Related]
11. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid]. Stiehl A; Raedsch R Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928 [No Abstract] [Full Text] [Related]
12. [Sclerosing cholangitis (primary, secondary)]. Oda M; Kamegaya Y; Shimazu M; Yokomori H Ryoikibetsu Shokogun Shirizu; 1996; (9):11-6. PubMed ID: 8705424 [No Abstract] [Full Text] [Related]
13. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM; Rybicki LA; Lashner BA Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486 [TBL] [Abstract][Full Text] [Related]
14. Education and imaging. Hepatobiliary and pancreatic: sclerosing cholangitis associated with critical illness. Tian M; Lv Y; Li J J Gastroenterol Hepatol; 2010 Apr; 25(4):842. PubMed ID: 20492345 [No Abstract] [Full Text] [Related]
15. Secondary sclerosing cholangitis following major burn. Ben-Ari Z; Levingston D; Weitzman E; Haviv-Yadid Y; Cohen-Ezra O; Weiss P; Zuckerman E; Inbar Y; Amitai M; Rimon U; Goder M; Haik J Ann Hepatol; 2015; 14(5):695-701. PubMed ID: 26256898 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and medical therapy of primary sclerosing cholangitis. van Milligen de Wit AW Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135 [No Abstract] [Full Text] [Related]
17. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy. Fong DG; Lindor KD Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026 [No Abstract] [Full Text] [Related]
18. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]. Stiehl A Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002 [No Abstract] [Full Text] [Related]
19. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine. Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534 [No Abstract] [Full Text] [Related]